Auxora for the Treatment of Patients With Acute Pancreatitis and Accompanying Systemic Inflammatory Response Syndrome: Clinical Development of a Calcium Release-Activated Calcium Channel Inhibitor

To assess the safety of Auxora in patients with acute pancreatitis (AP), systemic inflammatory response syndrome (SIRS), and hypoxemia, and identify efficacy endpoints to prospectively test in future studies. METHODS: This phase 2, open-label, dose-response study randomized patients with AP, accompa...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruen, Charles, Miller, Joseph, Wilburn, John, Mackey, Caleb, Bollen, Thomas L., Stauderman, Kenneth, Hebbar, Sudarshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104014/
https://www.ncbi.nlm.nih.gov/pubmed/33939666
http://dx.doi.org/10.1097/MPA.0000000000001793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104014/
https://www.ncbi.nlm.nih.gov/pubmed/33939666
http://dx.doi.org/10.1097/MPA.0000000000001793

Ejemplares similares